Microbion's Unattributed VC Round

Microbion raised a round of funding on January 05, 2017.

Microbion, a clinical stage biopharmaceutical company, is developing MBN-101 as the first product in a new class for the treatment of resistant and difficult to treat infections. MBN-101 has broad spe…

Articles about Microbion's Unattributed VC Round: